catalyst · primary record
EMPAGLIFLOZIN
FDA filing · 2026-09-17
| Company | RIDHISIDHI, PLLC |
|---|---|
| Ticker | Not stated |
| Impact | medium |
| Detail | Original Application · Tentative Approval |
| Source | openFDA |
Provenance
- Source: openFDA
- Fetched at: 2026-10-30T14:45:46.899Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: RIDHISIDHI, PLLC:EMPAGLIFLOZIN:2026-09-17:Original Application · Tentative Approval
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Empagliflozin · trial
- Empagliflozin · approval
- Empagliflozin · compound